Shares of National Vision Holdings, Inc. (NASDAQ:EYE – Get Free Report) crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $17.03 and traded as high as $17.31. National Vision shares last traded at $17.13, with a volume of 2,128,334 shares traded.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on EYE. Guggenheim set a $27.00 price target on National Vision in a research note on Friday, September 11th. Citigroup lowered their price target on National Vision from $39.00 to $35.00 and set a “buy” rating on the stock in a research report on Thursday, August 13th. Morgan Stanley dropped their price objective on National Vision from $22.00 to $21.00 and set an “equal weight” rating on the stock in a report on Thursday, August 13th. UBS Group cut their price objective on National Vision from $36.00 to $34.00 and set a “buy” rating for the company in a research report on Thursday, August 13th. Finally, Roth Capital restated a “buy” rating and issued a $27.00 price objective on shares of National Vision in a research report on Thursday, August 13th. Seven analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $29.82.
Check Out Our Latest Research Report on National Vision
National Vision Trading Up 3.3%
The company has a debt-to-equity ratio of 0.25, a current ratio of 0.59 and a quick ratio of 0.27. The firm has a market capitalization of $1.35 billion, a PE ratio of 28.08, a P/E/G ratio of 1.22 and a beta of 0.98. The company’s fifty day simple moving average is $17.03 and its 200-day simple moving average is $21.34.
National Vision (NASDAQ:EYE – Get Free Report) last announced its earnings results on Wednesday, August 12th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.07. The business had revenue of $498.81 million for the quarter. National Vision had a net margin of 2.47% and a return on equity of 6.78%. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.18 EPS. As a group, sell-side analysts expect that National Vision Holdings, Inc. will post 0.65 earnings per share for the current fiscal year.
Institutional Investors Weigh In On National Vision
Several institutional investors have recently bought and sold shares of EYE. BlackRock Inc. purchased a new position in shares of National Vision in the second quarter worth about $230,295,000. Wellington Management Group LLP boosted its position in National Vision by 39.6% during the second quarter. Wellington Management Group LLP now owns 7,669,853 shares of the company’s stock worth $145,804,000 after acquiring an additional 2,173,887 shares during the last quarter. William Blair Investment Management LLC acquired a new position in National Vision during the second quarter worth about $90,248,000. Dimensional Fund Advisors LP boosted its position in National Vision by 1.1% during the first quarter. Dimensional Fund Advisors LP now owns 3,062,191 shares of the company’s stock worth $79,304,000 after acquiring an additional 32,595 shares during the last quarter. Finally, Bank of America Corp DE grew its stake in National Vision by 6.8% during the 1st quarter. Bank of America Corp DE now owns 1,175,370 shares of the company’s stock valued at $30,442,000 after acquiring an additional 74,607 shares in the last quarter.
National Vision Company Profile
National Vision Holdings, Inc is an optical retail company that provides prescription eyewear, contact lenses, eye examinations and related vision-care services. The company operates primarily in the United States through a network of retail optical locations and digital channels.
Its principal brands include America’s Best Contacts & Eyeglasses, which offers eye exams, prescription glasses and contact lenses at value-oriented prices, and Eyeglass World, which provides similar products and services.
Further Reading
- Five stocks we like better than National Vision
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.
